Publications by authors named "Sudeep Prajapati"

Claim this Profile
C
Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer.
Craig Furman, Xiaoling Puyang, Zhaojie Zhang, Zhenhua J Wu, Deepti Banka, Sudeep Prajapati

Mol Cancer Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of FGFR4 and VEGFR signaling enhances efficacy in FGF19 driven hepatocellular carcinoma.
Xuesong Zhao, Jaya Julie Joshi, Daniel Aird, Craig Karr, Kun Yu, Sudeep Prajapati

Am J Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Aminopyrazole Derivatives as Potent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR2 and 3.
Ryan A Brawn, Andrew Cook, Kiyoyuki Omoto, Jiyuan Ke, Craig Karr, Sudeep Prajapati

ACS Med Chem Lett· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen Receptor Covalent Antagonists: The Best Is Yet to Come.
Craig Furman, Ming-Hong Hao, Sudeep Prajapati, Dominic Reynolds, Victoria Rimkunas

Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical pharmacokinetics and in vitro metabolism of H3B-6545, a novel selective ERα covalent antagonist (SERCA).
Nathalie Rioux, Sherri Smith, Manav Korpal, Morgan O'Shea, Sudeep Prajapati

Cancer Chemother Pharmacol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERα and ERα Breast Cancer.
Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Zhenhua J Wu, Deepti Banka, Sudeep Prajapati

Cancer Discov· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers.
Michael Seiler, Akihide Yoshimi, Rachel Darman, Betty Chan, Gregg Keaney, Sudeep Prajapati

Nat Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.
Jaya Julie Joshi, Heather Coffey, Erik Corcoran, Jennifer Tsai, Chia-Ling Huang, Sudeep Prajapati

Cancer Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex.
Teng Teng, Jennifer Hc Tsai, Xiaoling Puyang, Michael Seiler, Shouyong Peng, Sudeep Prajapati

Nat Commun· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total synthesis of 6-deoxypladienolide D and Assessment of Splicing Inhibitory Activity in a Mutant SF3B1 cancer cell line.
Kenzo Arai, Silvia Buonamici, Betty Chan, Laura Corson, Atsushi Endo, Sudeep Prajapati

Org Lett· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annulation of thioimidates and vinyl carbodiimides to prepare 2-aminopyrimidines, competent nucleophiles for intramolecular alkyne hydroamination. Synthesis of (-)-crambidine.
Nicholas R Perl, Nathan D Ide, Sudeep Prajapati, Hahdi H Perfect, Sergio G Durón

J Am Chem Soc· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis